From: Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD
Reference | Biomarkers | N | AUROC | Cutoff value | Se (%) | Sp (%) | PPV (%) | NPV (%) |
---|---|---|---|---|---|---|---|---|
Dixon [48] | HAIR score | 105 | 0.90 | score>2 | 80 | 89 | n/a | n/a |
(hypertension, ALT>40 U/L, IR index>5) | ||||||||
Palekar [49] | age≥50 years, female gender, AST≥45 U/L, | 80 | 0.76 | score≥3 | 73.7 | 65.7 | 68.2 | 71.4 |
BMI≥30 kg/m2, AAR ratio≥0.8, HA≥55 mcg/L | ||||||||
Poynard [50] | NashTest | 257 | 0.78 | n/a | 33 | 94 | 66 | 81 |
(age, sex, height, weight, triglyceride, GGT, | ||||||||
cholesterol, alpha2macroglobulin, AST, ALT, | ||||||||
apolipoprotein A1, haptoglobin, total bilirubin) | ||||||||
Gholam [51] | AST, presence of diabetes | 97 | 0.82 | 8.22 | 76 | 66 | n/a | n/a |
Campos [52] | NASH Clinical Scoring System for Morbid | 186 | 0.80 | 0-2 | 7 | 93 | ||
obesity (hypertension, type 2 diabetes, | 3-4 | 27 | 73 | |||||
AST≥27 U/L, ALT ≥27 U/L, sleep apnea, | 5 | 59 | 41 | |||||
non-black race) | 6-7 | 93 | 7 | |||||
Ulitsky [53] | diabetes, ALT >40 U/L, triglyceride >150 | 253 | 0.76 | 0-1 | 10.6 | 89.4 | ||
mg/dL, sleep apnea | 2-3 | 24.7 | 75.3 | |||||
4 | 60 | 40 | ||||||
5 | 75 | 25 | ||||||
Shimada [54] | adiponectin≤4 mcg/mL, HOMA-IR≥3, | 85 | n/a | all 3 +ive | 94 | 74 | 94 | 74 |
type IV collagen 7S≥5 ng/mL | ||||||||
Tarek [56] | CK18 fragments, sFas | 95 | 0.93 | −0.5509 | 88 | 89 | n/a | n/a |
Younossi [57] | NASH Diagnostics | 101 | 0.908 | 0.2772 | 94.5 | 70.2 | 60 | 97.1 |
(cleaved and intact CK18 levels, | ||||||||
serum adiponectin and resistin levels) | ||||||||
Sookoain [58] | BMI, waist circumference, ALT, AST, AP, | 101 | 0.795 | n/a | n/a | n/a | n/a | n/a |
GGT, HOMA, CRP, sICAM-1 | ||||||||
Sumida [59] | NAFIC score | 177† | 0.851† | 1 | 94 | 48 | 31 | 86 |
[serum ferritin (≥200 ng/mL for female, | 2 | 66 | 91 | 90 | 67 | |||
≥300 ng/mL for male), fasting insulin ≥10 | 442¥ | 0.782¥ | 1 | 88 | 43 | 66 | 75 | |
μU/mL, type IV collagen ≥5 ng/mL] | 2 | 60 | 87 | 85 | 64 | |||
Younossi [60] | NAFLD Diagnostic Panel | 79 | 0.81 | 0.221 | 91.2 | 47.4 | 60.8 | 85.7 |
(diabetes, gender, BMI, triglycerides, | 0.3641 | 79.4 | 73.7 | 73 | 80 | |||
apoptotic and necrotic CK18 fragments) | 0.6183 | 44.1 | 92.1 | 83.3 | 64.8 |